Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer therapeutics and increased demand from patients for affordable and quality care. Furthermore, the global push toward precision medicine has gradually propelled the uptake of innovative platforms such as Next-generation Sequencing (NGS) and liquid biopsy for gradual adoption into mainstream clinical diagnosis. The study examines the APAC oncology diagnostics market, focused on 6 high-prevalence cancers, namely, breast, lung, prostate, colorectal, cervical, and ovarian cancer. The scope of the study includes 10 countries: Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, and Vietnam, with country-level market share and top trends and opportunities driving the oncology diagnostics market. Furthermore, the study identifies the top growth opportunities and market trends that are set to transform the future landscape of oncology diagnostics in APAC. NGS solutions are gradually moving from research to clinical applications, with major regional companies investing in molecular diagnostics as a future growth segment. Luye Pharma’s acquisition of Vela Diagnostics, the Genome Asia 100K initiative by Macrogen, multiplexed diagnostic solutions from Seegene Diagnostics, and liquid biopsy tools from Sysmex Inostics are a few examples of trending topics in APAC that will impact the oncology diagnostics market. The market, whose revenue stood at $873.7 million in 2016, is expected to generate a revenue of $1,149.1 million by 2021, growing at a Compound Annual Growth Rate (CAGR) of 5.6%.

In addition to the above-mentioned data points, the study also provides information in terms of the key participants across the market by different cancer types as well as some of the new entrants in the market.

The following are some key questions that this study will answer.
•     What is the current market scenario for oncology diagnostics in Asia?
•     What are the emerging cancers in Asia with high-growth opportunities in In-vitro Diagnostics (IVD)?
•     What are the regional dynamics currently trending in Asia to combat the rising prominence of cancer, precisely through early screening and surveillance programs?
•     What is the penetration of novel diagnostic solutions across the oncology care continuum?
•     What are the challenges and barriers to address in accelerating the uptake of novel screening or cancer diagnostic tests in Asia?
•     What are the growth opportunities for IVD companies to tap into in the APAC oncology diagnostics market?

Table of Contents

1. Executive Dashboard
Purpose of This APAC Oncology Diagnostics Study
5-Step Process to Transformational Growth
Strategic Imperatives for APAC OncoDx Companies
Market Segmentation
Key Findings—How is This Market Important to You?
8 Big Market Themes for APAC Oncology Dx
2. Growth Environment—Market Overview
Market Size Estimation Methodology
Market Overview
Industry Value Chain
Market Drivers and Restraints
Trends in APAC Oncology Diagnostics Market
Key Companies to Watch
3. Growth Environment—Market Forecasts
Revenue Forecast
4. Growth Environment—Regional Analysis
China
India
Japan
South Korea
Australia
ASEAN
5. Growth Pipeline, Strategy, and Implementation
Growth Opportunity Matrix
Key Growth Opportunities—Preview
Growth Opportunity 1—Artificial Intelligence (AI)
Growth Opportunity 2—Vertical Investments
Growth Opportunity 3—Frugal Innovation in Cancer Screening
Growth Opportunity 4—Emerging Biomarkers
Growth Opportunity 5—Digital Solutions
Growth Opportunity 6—Emerging Markets
Companion Diagnostics—An Opportunity
6. Breast Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Breast Cancer Diagnostics
7. Lung Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Lung Cancer Diagnostics
8. Colorectal Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Colorectal Cancer Diagnostics
9. Ovarian Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Ovarian Cancer Diagnostics
10.
11. Cervical Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Cervical Cancer Diagnostics
12. Prostate Cancer
Market Overview
Market Segmentation by Technology
Revenue Forecast by Technology Type
Percent Revenue Breakdown by Country
Competitor Scenario and Market Share Analysis
Key Companies to Watch
Emerging Technologies in Prostate Cancer Diagnostics
13. Conclusion
5 Competitive Keys for Success in APAC Cancer Diagnostic Space
Legal Disclaimer

Infographic



List of Figures & Charts

1. Oncology Diagnostics Market: Industry Value Chain, APAC, 2016
2. Oncology Diagnostics Market: Key Market Drivers and Restraints, APAC, 2017–2021
3. Oncology Diagnostics Market: Cancer Diagnostics Technology, APAC, 2016–2021
4. Oncology Diagnostics Market: Technology Penetration by Cancer type, APAC, 2016
5. Oncology Diagnostics Market: Companion Diagnostics—An Opportunity, APAC, 2016
6. Breast Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
7. Breast Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
8. Breast Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
9. Lung Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
10. Lung Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
11. Lung Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
12. Colorectal Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
13. Colorectal Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
14. Colorectal Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
15. Ovarian Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
16. Ovarian Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
17. Ovarian Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
18. Cervical Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
19. Cervical Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
20. Cervical Cancer Diagnostics Market: Emerging Technologies, APAC, 2016
21. Prostate Cancer Diagnostics Market: Segmentation by Technology and Function, APAC, 2016
22. Prostate Cancer Diagnostics Market: Key Companies to Watch, APAC, 2016
23. Prostate Cancer Diagnostics Market: Emerging Technologies, APAC, 2016


1. Oncology Diagnostics Market: Revenue Share by Cancer Type, APAC, 2016–2021
2. Oncology Diagnostics Market: Percent Revenue Breakdown by Cancer Type, APAC, 2016 and 2021
3. Oncology Diagnostics Market: Growth Opportunity Matrix, APAC, 2016–2021
4. Oncology Diagnostics Market: Breast Cancer Diagnostic Pathway, APAC, 2016
5. Breast Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
6. Breast Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
7. Breast Cancer Diagnostics Market: Diagnostic Patterns, APAC, 2016
8. Breast Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
9. Oncology Diagnostics Market: Lung Cancer Diagnostic Pathway, APAC, 2016
10. Lung Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
11. Lung Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
12. Lung Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
13. Oncology Diagnostics Market: Colorectal Cancer Diagnostic Pathway, APAC, 2016
14. Colorectal Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
15. Colorectal Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
16. Colorectal Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
17. Oncology Diagnostics Market: Ovarian Cancer Diagnostic Pathway, APAC, 2016
18. Ovarian Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
19. Ovarian Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
20. Oncology Diagnostics Market: Ovarian Cancer Market Share Analysis, APAC, 2016
21. Oncology Diagnostics Market: Cervical Cancer Diagnostic Pathway, APAC, 2016
22. Cervical Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2015–2021
23. Cervical Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
24. Cervical Cancer Diagnostics Market: Market Share Analysis, APAC, 2016
25. Oncology Diagnostics Market: Prostate Cancer Diagnostic Pathway, APAC, 2016
26. Prostate Cancer Diagnostics Market: Revenue Forecast by Technology Type, APAC, 2016
27. Prostate Cancer Diagnostics Market: Percent Revenue Breakdown by Country, APAC, 2016
28. Prostate Cancer Diagnostics Market: Market Share Analysis, APAC, 2016



Related Research

Release Date : 04-Dec-2015

Region : Asia Pacific

Release Date : 30-Sep-2015

Region : Asia Pacific

Release Date : 21-Aug-2015

Region : Asia Pacific

Release Date : 10-Jul-2015

Region : Asia Pacific

Release Date : 30-Jun-2015

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.